Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Some of us even added a few. Hope were right.
What that mean. Promark EXCLUSIVE VALUE-ADDED DISTRIBUTOR.
Thank GOD for all the cheap ones I added on the way down from .60.
They have not built any new refineries because there is no need for them. In fact at least 3 were closed last year. In the early 50's 10 miles per gallon was common. Trucks got 4 or 5. Now cars get 30. The only way they would build a new one. Either the feed stock would come out of coal or shale that would require a whole new way of doing it. Then it would have to be cheaper than converting an old refinery.
This stock is starting to look real good. Only one day to go. No one is giving it up.
I am afraid to say this. But if it closes at this level or higher tommorow. I will be forced to reenter the market on the buy side. That being said. Next week is DUMP WEEK. A time when I buy a lot. If this turkey can stay up next week. We may have a ball game.
Glad to see your still here. I was starting to feel like the MAYTAG repair man. Rumor is the stock will not be under a dollar in 6 to 9 months from now. I hope its half right.
Another Successful Year at Divine Skin
December 21, 2011. The team at Divine Skin (DSKX.OB) has been working to maintain strong growth and exceed expectations across its diverse consumer goods business and accelerate development through its strong biotechnology program. Some highlights for the year include:
RECORD 2010 REVENUE - Divine Skin started the year by announcing record sales for 2010 ($5.4 million), up $1.9 million or 55 percent over 2009.
RECORD 2011 QUARTERS - We posted record sales again in Q1 ($2.2 million) and Q2 ($2.3 million) of this year, and the first nine-month period ($6.6 million) was up 74 percent, reaping the benefits of production investments and explosive demand.
SALONS - In May, DS Laboratories announced new agreements with four distributors that supply 27,000 salons and professionals in the Northwest, Southwest, Southeast, and Midwest.
FANTASTIC SAMS - DS Labs installed more locations of the huge Fantastic Sams chain of salons, supplying unique product, professional training, and promotional assistance.
NEIMAN MARCUS - Prestigious fashion retailer Neiman Marcus picked up our super-premium Sigma Skin line for hair and skin.
AUDITORS -Top-30 auditing firm Cherry, Bekaert & Holland LLP began advising us, bringing valuable experience with publicly traded manufacturers and lending credibility to financial statements.
BRAZIL - A new Brazilian distributor conducted the successful trials and earned the required certificates needed to import into that burgeoning market of 201 million eager consumers.
ORAL ANALGESIC - We announced our foray into pharmaceuticals with an oral analgesic to compete with Tylenol, Advil, and aspirin. Like our other products, it targets the market that appreciates more advanced biotechnology.
NUTRAORIGIN - Expanding into nutritional supplements, Divine Skin acquired rights to NutraOrigin, with 63 formulas that can be incorporated easily into any health regimen.
RANBAXY LABS - We announced a global partnership with India’s largest pharmaceutical company, Ranbaxy Laboratories, to sell DS Labs products worldwide.
NANOXIDIL - The company introduced a new compound, Nanoxidil, engineered to surpass minoxidil for efficacy and tolerability. It debuted in new Spectral.DNC-N.
NUTRAORIGIN - Expanding into nutritional supplements, Divine Skin acquired rights
to NutraOrigin, with 63 formulas that can be incorporated easily into any health regimen.
ASTRESSIN-B - DS Labs became the first biotech brand to commercialize a hair-growth treatment based on astressin-B, a peptide (protein fragment) newly discovered to regrow hair on bald mice. It debuted in new Spectral.F7.
CAPITALIZATION - Divine Skin secured new capital through Littlebanc Advisors to be used to build our mounting inventory and service our expanding distribution.
API SOLUTION 9 - Polaris Research rolled out API Solution 9, a customizable topical kit to be sold by physicians. It delivers unprecedented concentrations of minoxidil, finasteride, and alfatradiol, and it has no competitor.
WHOLE FOODS - NutraOrigin tested successfully in Whole Foods, a chain of 297 retail stores in the United States, plus seven in Canada and six in the United Kingdom.
ZACKS INVESTMENT RESEARCH - Zacks gave Divine Skin an “outperform” rating and a six-month target price of $0.65 per share.
Divine Skin announces that its plans for expansion in 2012 are even more aggressive, and that they will further diversify its core business.
About Divine Skin
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions with broad spectrum of activity across arange of personal care applications. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in theUnited Kingdom . The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).
It feels a lot better. Next week will tell us where its going.
WE heard the same thing 5 years ago. All good points, but it never happened. Add in the options and warrents. Plus 3 to 5 years before they get permits and equipment. There will be lots more shares to issue before you see mining. That being said, I know little about the rest of the company. If you are an active trader. You can play with it. But its best to buy companys that are in production. BEST OF LUCK TO ALL
THE OLD GUY
For what its worth. I got a FRIDAY BUY RULE today on this stock.
Be carefull or that Northern Graphite stock. Thats the old IDSM property. I went to see it some years ago. Not much there. I know little of the new company. But that being said. Unless they have deep pockets, it will go no where soon. Also they may have to sell a ton of stock to finance it to production. I wish he did not mention it. It makes all of his comments SUSPECT.
BEST OF LUCK
THE OLD GUY
CellerateRX® added to list of preferred products for Golden Living Healthcare Network
FORT WORTH, Texas, December 12, 2011 PRNewswire-FirstCall -- Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leading innovator in advanced wound care solutions, today announced that Fort Smith, AR based Golden Living has added CellerateRX® to its formulary and is now on the list of preferred products approved for use within its healthcare network. Golden Living, one of the country's premiere integrated healthcare service companies, provides services for the elderly and disabled including nursing home care, rehabilitation therapy, hospice care, home health services and temporary staffing services. The company employs more than 40,000 and has in its care about 30,000 patients daily.
“Being added to the formulary list at Golden Living is an important imprimatur for CellerateRX. Our flagship product will now be a choice in their over 300 Living Centers including skilled nursing locations, as well as in their 68 hospice and home health locations. With our acquisition of Juventas LLC and its established sales force, we will be able to educate and establish sales quickly at each Golden Living Facility,” said Bryant Gaines, Chief Operating Officer of Wound Management Technologies. He further stated, “The agreement is part of our long-term plan to penetrate the professional healthcare markets worldwide. The Company expects to sign additional agreements with major healthcare system clients that will further establish CellerateRX® as a leading product in the area of wound management.”
“We are very excited about the opportunity to work with the Golden Living facilities,” said Cathy Bradshaw, President of WNDM subsidiary Wound Care Innovations. “CellerateRX® is FDA cleared for use on all acute and chronic wounds except for 3rd degree burns and has been shown to provide quality outcomes in a cost effective manner. This is essential for healthcare providers.”
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management’s primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage. More information can befound on the company's web sites: http://www.wmgtech.com and http://www.celleraterx.com.
Follow us on:FACEBOOK | TWITTER | LINKEDIN
About Golden Living, Inc:
Golden Living is a family of companies that specialize in recovery care. Its mission is to help people recover health and improve quality of life through a network of healthcare services, including rehab, home care, assisted living, skilled nursing care and hospice. The Golden Living family of companies include Golden LivingCenters, Aegis Therapies, AseraCare Hospice and Home Health, and 360 Healthcare Staffing. There are more than 300 Golden LivingCenters in 21 states. Golden Living also offers assisted living services at more than 40 locations. In addition, the Golden Innovations companies partner with more than 1,000 nursing homes, hospitals and other health care organizations in 37 states and the District of Columbia. Collectively, the Golden Living family of companies has more than 42,000 employees who provide quality healthcare to more than 60,000 patients every day. More information can be found on the company's web sites:http://www.goldenliving.com
Safe Harbor Statement:
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
For Wound Management Technologies Shareholder Information please call (917) 974-9872 or visit http://www.wmgtech.com
Well said. Back to my origanal statements when merger was first announced. We don't know how much sales PROMART really had. They gave us a figure that was not current. They had lost a ton of vendors in the last 2 years. Also gross means nothing, NET is where its at. They may of wanted too much for what they had to offer. We will never know. SIG may be a yo yo and he has lied to me in the past. But he has a backround in this type of business. That says he knows what hes looking at. Just like the guy flying the plane. He may not be worried about your ass but hes on the same plane. He want's the loot, just like we do.
BEST OF LUCK TO ALL
THE OLD GUY
Zacks Keeps Outperform Recommendation on Divine Skin (DSKX) and a Six Month Price Target of $0.65
See the full report here
Divine Skin Inc. (DSKX) leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions with broad spectrum of activity across a range of personal care applications. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom . The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).
Zacks Small-Cap Research Report
Perhaps a new suitor has arrived on the scene. The old one may take time to clear away.
Nov. 30, 2011 -- Divine Skin Inc. (DSKX.ob) confirmed that NutraOrigin, its brand of 63 premium nutritional supplements, had been tested successfully in four of the roughly 300 US locations of Whole Foods Market Inc., and that NutraOrigin would propagate throughout the upscale chain in 2012.
Distribution began with NutraOrigin's Omega line, the first brand of high-potency omega-3 fatty acids proven effective in large-scale clinical trials. During a recent double-blind study conducted for a US government agency, volunteers taking the NutraOrigin product improved their reaction time and accuracy while reducing drowsiness and anxiety. When the Whole Foods rollout is complete, NutraOrigin's Vitamin and Clinical lines will also be available.
Divine Skin CEO Daniel Khesin said, "NutraOrigin fits perfectly into the Whole Foods business model. We expect this deal to yield significant new revenue for both companies."
In the United States , all manufacturers' revenues from vitamins and nutrients for human use total $9 billion per year, and fish oils alone top $280 million , according to the US Census Bureau.
About Divine Skin
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions with broad spectrum of activity across a range of personal care applications. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom . The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).
About NutraOrigin
Manufactured in the United States , the nutritional supplements of NutraOrigin set new standards of efficacy because the potent formulas are engineered to address the real-world health concerns of consumers.
The Omega line, demonstrated in clinical trials to boost mental function, now comprises 28 SKUs, which include softgels with fish oil, krill oil, and other sources of omega-3 fatty acids, plus shakes in pleasant fruit flavors, gummies for kids, and oils for pets.
The Clinical line has 24 SKUs. Its comprehensive blends target users concerned about a variety of health issues.
The Vitamin line, with 11 SKUs, includes tablets, softgels, and gummies targeted to men, women, kids, and seniors.
About Whole Foods
With 297 retail stores in the United States , seven in Canada , and six in the United Kingdom , Whole Foods Market Inc. has created a channel for the highest quality, most flavorful, least processed foods and nutritional supplements available.
The Texas -based company, founded in 1980 with one small store in Austin , now generates $9 billion per year and employs more than 58,300 team members on a mission it calls "Whole Foods - Whole People - Whole Planet." The market sources fine natural foods and nutritional supplements to improve customers' health and support sustainable agriculture.
Whole Foods is ranked among Fortune magazine's "100 Best Companies to Work For," and it sponsors food banks, micro-lending operations, and neighborhood events
WNDM to Acquire Medical Device Distributor Juventas; Bryant Gaines Named WNDM COO Effective Immediately
Posted on November 30, 2011 by wmgtech
FORT WORTH, Texas, November 30, 2011 PRNewswire-FirstCall — Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in the advanced wound care solutions market, today announced that it had signed a letter of intent (LOI) to acquire Juventus LLC. Fort Worth, TX-based Juventas, controlled by former Biomet Texas affiliates Bryant Gaines and Jeff Ott, operates a nationwide distributor network. Juventas products are used primarily by medical specialists in both surgical, non-surgical therapy and regenerative medicine. The acquisition would be an all-stock deal that would result in the owners of Juventas obtaining 12.5 million shares of WNDM at closing, the ability to earn additional shares based on revenue targets increasing the number of shares to 22.5 million shares, and representation on the WNDM Board of Directors. Closing of the acquisition is subject to a number of conditions, including, but not limited to, the audit of Juventas being completed by the first quarter of 2012.
Transaction Adds Financial Strength and Sales Force
The transaction will allow for revenue growth by acquiring Juventas, which will immediately position it to create greater value for its shareholders and allow the Company to manage its cash flow. It will allow both companies to combine their revenue streams to increase sales efforts and focus. The combined companies will be able to launch products into the market more effectively with Juventas having over 25 years experience in these markets. Also this will immediately allow WNDM to have direct access to the Juventas Distributor Network.
Juventas is a successful company with a substantial commission-based sales force focused on advancement in the biologics and regenerative medicine. Both parties believe there is significant revenue and cost synergies they will be able to achieve as a combined company to significantly expand sales and profits for Wound Management.
Acquisition Provides New Management
As part of the agreement, Juventas principals Jeff Ott and Bryant Gaines have agreed to provide their management services to WNDM. Juventas COO Bryant Gaines has been named COO of Wound Management effective immediately. He will work with CEO Scott Haire and President Deborah Hutchinson to integrate the Juventas distribution network into WNDM and plan the strategic direction of the combined companies.
According to Bryant Gaines, “Juventas chose to be acquired by Wound Management because of the opportunities we see in the combined company. We know that with WNDM’s proven products and our proven distribution practices, growth will be accelerated at a rate WNDM has not previously experienced. We are currently evaluating additional core products to add to our current offering for 2012 along with ancillary products to compliment our existing product offerings.”
“Bryant Gaines and I are excited to become a key part of the WNDM Management team”, added Jeff Ott, Juventas President & CEO. “The synergy in the acquisition is in the leveraging of past managerial experience in medical device distribution with the near limitless potential of CellerateRX and the other product lines developed by Wound Management. Both parties in this acquisition will define success by how well and how quickly we penetrate markets and build shareholder value.”
“Goal is to Build Shareholder Value”
“The agreement to acquire Juventas is a watershed event for Wound Management Technologies,” according to Chairman and CEO Scott Haire. “The marrying of our advanced wound care products with the superior medical device distribution network developed by Jeff Ott and Bryant Gaines at Juventas creates a value-driven enterprise for a fast growing public company and fully aligns all parties on increasing value. The deal is driven by one goal: to build long-term WNDM shareholder value by making CellerateRX and our other product lines the leading products in their respective markets. Jeff and Bryant, based on their previous relationships with major medical device manufacturers and other major players in the market, also have the ability to open many doors to further expedite business opportunities and grow revenue.”
Additional information concerning the Acquisition Letter of Intent and other related agreements can be found in Wound Management Technologies filings on the Securities and Exchange Commission EDGAR system website http://www.sec.gov/. Please read all related documents prior to making any investment decision based upon the press release above.
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management’s primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA, cleared. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage. More information can be found on the company’s web sites: http://www.wmgtech.com and http://www.celleraterx.com.
Follow us on: FACEBOOK | TWITTER | LINKEDIN
About Juventas, LLC
Juventas, led by Bryant Gaines and Jeff Ott, is a former affiliate of Biomet Texas, Ltd., the largest Biomet Distributor. Juventas and its affiliates market products used primarily by medical specialists in both surgical and non-surgical therapy and reginerative medicine. Headquartered in Fort Worth, Texas, Juventas currently distributes products all over the United States.
Safe Harbor Statement:
The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products in development and any other statements not constituting historical facts are “forward-looking statements,” within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company’s actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company’s operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company’s SEC filings, which could cause the company’s actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
For Wound Management Technologies Shareholder Information please call (917) 974-9872 or visit http://www.wmgtech.com
I do not want to start an aurgument. But in till you see what the new man does, how can you make that comparison ? It is obvious that the old man is tired or has lost intrest. Easy to understand. this stock has so much potential. But is being run by a clown that can't seem to get his act together.The hardist thing to do. Is not accept new ideas. But to let go of the old ones.Best of luck to all. THE OLD GUY
Let the new blood stay. Fresh meat is good. May bring a new perspective.
Out of funds at this point. Bought it all the way down to .21. Have 500000 now. need .37 to break even.
Big volume, looks like its going to turn up.
Divine Skin Posts Q3 Revenue of $2.1 Million, Up 35% from 2010
Nov. 15, 2011 -- Biotechnology leader Divine Skin Inc., (OTC Bulletin Board: DSKX) which develops personal care products, posted revenue of $2.1 million for the third quarter, up 35 percent from 2010. The rapidly expanding company reported nine-month revenue of $6.6 million , up 74 percent from last year.
"We are on track for another record-breaking year," said Divine Skin CEO Daniel Khesin . "These days, there are so many opportunities to commercialize new scientific discoveries, and we are taking full advantage. We couldn't be in a better position right now."
The positive results came after a busy quarter of big announcements.
In July: Divine Skin expanded into the lucrative market for supplements by partnering with NutraOrigin, developer of 63 blends of nutritional formulas; and the company launched a global partnership with India 's huge Ranbaxy Laboratories to sell its DS Laboratories line of hair-growth treatments worldwide.
In August: Divine Skin debuted a new molecule, Nanoxidil, designed to stimulate follicles at the vertex of the scalp, eventually to surpass minoxidil for efficacy and tolerability; and it entered into new distribution agreements for South Korea , Canada , Australia , Taiwan , South Africa , Belgium , and Finland .
In September: Divine Skin launched the market's first topical treatment to incorporate astressin-B, a complex peptide newly discovered to regrow hair on bald mice. The company also became the first to synthesize the peptide for human use in a cosmetic product, marketed as Spectral.F7 under the DS Laboratories brand.
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom . The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).
Divine Skin (DSKX) Rolls Out Polaris API Solution 9: A New Technology for Physicians
Nov. 9, 2011 -- Biotech developer Divine Skin Inc. (OTC Bulletin Board:DSKX.ob which has been expanding the topical hair-growth segment, is rolling out that market's newest, most potent, only customizable system, Polaris API Solution 9, to be supplied by physicians for treatment through multiple methods of action.
With well-established materials like minoxidil sulfate, finasteride, alfatradiol, and other active ingredients, Polaris API Solution 9 is the most complete solution that can be used for hair loss, either by prescription or over the counter configured to the individual needs of the patient by physicians. The current sales leader contains only 5% minoxidil in a standard carrier.
"We are launching a new category," declared CEO Daniel Khesin, speaking on a conference call with investors. "We expect this line to change the game and to offer a powerful new tool for dermatologists that can really make a difference in their approach to treatment."
Half of all men will experience some hair loss by age 50, and they can only purchase the customized Polaris product through physicians, who can create the potent mix of active pharmaceutical ingredients (API).
Divine Skin, which posted revenue of $5.4 million in 2010 — up 55 percent over the previous year — creates a major new revenue stream with Polaris API Solution 9, and stockholders expect to benefit for several years.
In published clinical trials, each major component of the new API — minoxidil sulfate, finasteride, and alfatradiol — has proven to inhibit androgenic alopecia (male pattern baldness) effectively. The system also includes other auxiliary agents like apple polyphenol, copper peptides, nutrients, and conditioners to enhance the formula further.
"With very few options available," says Khesin, "Polaris API Solution 9 is by far the most viable option for physicians to quickly and easily customize the ideal treatment for their patients. We expect everyone to do very well with this product."
Besides hair growth, Divine Skin with a strong focus on personal care science and innovation, markets premium topical solutions and drugs with more than 60 SKUs. In the United States, revenue to all manufacturers of all pharmaceutical preparations acting on the skin totaled $3.8 billion in 2009, according to the US Census Bureau. Divine Skin now sells in more than 20 countries.
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).
Time to buy. Breaking out.
because I added 60,000 shares to my position at 1.44 GOD HATES ME
Look at the volume.
To buy whiskey. Its your only true friend. It never borrows money from you. Its always there when you need it. Sell all your stocks and BUY BUY BUY IT.
Go to dskx, read my post 17. This stock is very similar. But not as far along. Also smaller market.
October 5th, 2011 -- Divine Skin, Inc. (OTC Bulletin Board:DSKX) announced the completion of a $1.73 million equity capital raise. Littlebanc Advisors, LLC, acted as the sole placement agent and financial advisor for Divine Skin. The deal was funded by both private and institutional investors. The growing biotech developer will deploy the new capital to fill orders for its expanding pipeline of distributors in Europe, Mexico, and Japan, as well as in the United States.
"We chose Littlebanc because of its successful track record of providing unstructured equity growth capital to early-stage companies," said Daniel Khesin, CEO of Divine Skin. "We view Littlebanc's involvement as an endorsement of what we are achieving."
"Divine Skin's high-quality and proprietary products have allowed the company to achieve impressive revenue growth since inception," said Michael Margolies, CEO of Littlebanc Advisors. "This round of financing will allow Divine Skin to continue acquiring market share with their innovative products. We are very pleased to be working with another high-growth Florida company."
Divine Skin's recent achievements include:
• A record-setting $2.3 million in quarterly revenue for Q2 2011.
• The release of the world's first topical hair-growth treatment based on the breakthrough peptide astressin-B.
• The introduction of the new compound Nanoxidil, designed to surpass minoxidil for efficacy and tolerability, which will facilitate new international distribution agreements.
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009 (www.dskx.biz).
DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).
Not much. Time will tell. Its a nitch product. High priced and may be in the wrong outlets. We will know more in 2 quarters. Every one puts it in on the first go around. Its reorders that show what you have got going for you.
New news next week ?
This better stop going down, its running me out of money.
Divine Skin Inc. (OTC Bulletin Board:DSKX) has announced the release of the first topical hair-growth treatment based on astressin-B, a peptide newly discovered to regrow hair on bald mice. Divine Skin becomes the first biotech developer to synthesize and commercialize the peptide for human use in a cosmetic product, to be marketed as Spectral.F7 under the DS Laboratories brand.
"Astressin-B is a very complex peptide that is difficult to synthesize," said Divine Skin CEO Daniel Khesin. "So we are especially excited that the resulting product will be reasonably priced as well as cutting-edge, considering the extraordinary development schedule and cost."
Astressin-B sparked extensive media coverage worldwide and excitement around the biotech industry after a clinical study, conducted by the University of California Los Angeles and the Veterans Administration, was published in February. By applying the peptide (a protein fragment) subcutaneously to mice that had gone bald due to overexpression of stress hormones, scientists showed that astressin-B blocked receptors for corticotropin-releasing factor, involved in the stress response, and led to hair regrowth.
"We think this technology is years ahead of its time," continued Khesin. "It could provide significant benefits to many of our hair-loss customers. Spectral.F7 is another direct result of our relentless commitment to bring the latest technology to market first and always."
Spectral.F7, a booster that can be combined with other treatments or used alone, should begin shipping in October. It comes less than two months after Divine Skin introduced Nanoxidil, a new molecule designed to stimulate follicles at the vertex of the scalp and surpass minoxidil for efficacy and tolerability.
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).
Low volume, best sign we can get.
Why would you waste your time. Doing mental gymnastics over a ten piece puzzle. When all you have are two pieces.
The world has speeded up, but not this game. Unless you have inside information this is not a short term play. This is the kind of stock that 66 years ago when I started playing this game, every one would look for. It is a high margin product. It shows new distributers coming on line. It has new products. Pretend you are a farmer. By buying this stock, you are planting your seed. Now, give it time to grow. It will take 6 to 9 months for the new distributers to see how many reorders they get. If it looks good, they will start to buy the stock. You need at least 3 quarters of increasted growth to get people excited. Then when they put out news releases, it will mean something. Its way to early to promote this stock. Let it grow quitly, gives you more time to get a bigger position. You dont need 5 good stocks of 100 shares each. you need 1 good stock,and own 500 shares.
If you would of heard that gal talk about her marketing plan. You would have been very impressed. I know I was, and I am a harsh critic.
What can I say. Good luck finding a diffrent stock at forty cents with sales up 79 %. That just got an icon to come out of retiremement to join the company. I just got done adding a hundred thousand more shares of this company to my portfolio. You go do what ever trips your trigger. But for me, I will stay right here.
Divine Skin Posts Record Q2 Revenue of $2.33 Million, up 79 Percent From 2010
MIAMI BEACH, Fla., Aug. 23, 2011 -- Biotechnology leader Divine Skin Inc. (DSKX) posted its highest quarterly revenue, $2.33 million, in the second quarter. The expanding innovator of personal care solutions credits recent investments in production for clearing backorders and accelerating sales, which are 79 percent ahead of the same period in 2010.
"One of our challenges has been keeping up with demand," said Divine Skin CEO Daniel Khesin. "We have invested significant resources into setting up a more robust operations platform. Now we have the right people in the right jobs managing the right plans for procurement, manufacturing, and accounting infrastructure. We will therefore continue to scale up to much more impressive numbers."
The results come after a busy four months of announcements:
- Naming of cosmetics veteran Robin Powell, respected for his success at Sebastian and TIGI, as president.
- Explosive growth in salon distribution, including new channels totaling thousands of additional doors both domestically and abroad.
- Plans for an oral analgesic to compete with Tylenol, Advil, and aspirin.
- Expansion into advanced nutritional supplements with NutraOrigin.
- Agreement for India's largest pharmaceutical company to sell DS Laboratories treatments.
Divine Skin maintains a core focus on biotechnology development while building its consumer goods business. It's ongoing clinical studies for topical therapies have helped identify new molecules and many proprietary technologies in the treatment of common skin conditions such as alopecia. Recently the company has announced the launch of Nanoxidil, a new material to designed to surpass the efficacy of minoxidil. This kind of innovations within personal care is expected to maintain Divine Skin's position as a category leader in niche categories and drive strong revenue growth.
"At the heart of this business is the relentless drive for innovation of personal care products," commented Khesin. "Every day we are only getting better at what we do and creativity is reaching new horizons. Customers and shareholders should prepare for very exciting things to come," he added.
About Divine Skin
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, improve hygiene, and reduce cellulite and wrinkles. Bioavailability is enhanced through encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
NutraOrigin blends nutritional supplements that address the health concerns expressed by consumers, including fatigue, headache, obesity, mobility, menopause, erectile dysfunction, and others. In clinical trials for the US government, its Omega line proved to enhance mental function (www.nutraorigin.com).